Virus Diseases

377 trials 110 recruiting

Filter these 377 trials by phase, country and sponsor.

Open in Search →

Efficacy, immunogenicity, and safety of the 9vHPV vaccine in adult males 20 to 45 years of age Ended

2022-501974-21-00 Prevention of oral persistent infection caused by any o 5 2020-04-01
Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Expos… Ended

2022-501763-40-00 Pre-Exposure Prophylaxis of HIV-1 Infection 5 2016-12-13
A scientific study on a vaccine against HPV infection (human papilloma virus) (a vaccine for the prevention of cervical cancer and genit… Ended

2023-508683-30-00 9vHPV vaccine is indicated in females ≥ 9 years of age 5 2008-03-14
Evaluation of tolerance and pharmacokinetics profile of high dose favipiravir in healthy volunteers - FAVIDOSE Halted

2022-502871-49-00 healthy volunteers 3 2024-04-05
Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection Halted

2023-506143-42-00 Chronic Hepatitis B 4 2018-05-16
A phase 1 Clinical Trial to Evaluate Safety and Immunogenecity of HIV SOSIP v8.2 763 Vaccine in healthy individuals Ended

2025-520529-19-00 Human Immunodeficiency Virus (HIV) 1 2026-05-20
Phase IV multicenter trial to evaluate the immunogenicity and safety of the Seqirus licensed zoonotic influenza vaccine (H5N8) in adults pre… Ended

2025-522116-16-00 Avian Influenza 6 2025-12-08
Impact of influenza vaccination on nasal resident memory immune responses and respiratory peripheral memory immune responses Ended

2025-521217-46-00 Adults seeking active immunisation against the seasonal 6 2025-12-02
A Phase IV, open label, single arm trial to assess the safety and immunogenicity of BIMERVAX® LP.8.1 against SARS-CoV-2 variants. Ended

2025-524021-41-00 COVID-19 6 2025-10-28
Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy, immunogenicity and safety of one dose of… Ended

2024-520354-37-00 Influenza disease 4 2025-09-08
Study to Learn How Safe EV25 is and the Amount of EV25 in the Body Over a Period of Time, When Taken [CCI] as a Dry Powder via the Nose by A… Ended

2025-521783-35-00 Influenza virus 3 2025-07-10
A clinical study of MK-1289 in healthy adult men (MK-1289-001) Ended

2025-521395-63-00 COVID-19 Infection 1 2025-06-04
A phase 4, open-label study to evaluate the short-term innate immune response after administration of a COVID-19 mRNA vaccine (Comirnaty JN… Ended

2024-520304-26-00 COVID-19 6 2025-05-05
Study of Oral Weekly GS-1720 and GS-4182 Compared With Biktarvy in People With HIV-1 Who Have Not Been Treated Ended

2024-512505-66-00 HIV-1 Infection 10 2025-03-03
The safety and antibody response of the nasal COV2 vaccine against the SARS-CoV-2 virus Ended

2023-509725-49-00 Booster immunisation against COVID-19 disease caused by 1 2025-01-27
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AB-101 Following Oral Administration in Healthy and Chronic Hepatitis B Subj… Ended

2023-508312-39-00 Chronic hepatitis B virus Infection 1 2024-12-13
A study to learn how different amounts of the study medicine called PF-07941944 are tolerated in the body of healthy adults. Ended

2024-515421-28-00 RSV (Respiratory Syncytial Virus) 1 2024-11-28
Is dermal measles-mumps-rubella-vaccine administration better than regular injection? Ended

2023-503845-79-01 Measles, mumps, and rubella 4 2024-11-24
TURN-COVID Biobank: The Dutch cohort study for the evaluation of the use of neutralizing monoclonal antibodies and other antiviral agents ag… Ended

2024-515263-60-00 SARS-CoV-2 infection 6 2024-11-22
A Study to Learn About if the Study Medicine Called Ibuzatrelvir changes how the body process the other Medicine Dabigatran Etexilate in hea… Ended

2024-517797-14-00 severe acute respiratory syndrome coronavirus 2 (SARS-C 3 2024-11-19
A clinical study of MK-4646 in healthy people (MK-4646-002) Ended

2024-516626-63-00 HIV infection 3 2024-11-18
The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatm… Ended

2024-515436-76-00 influenza 2 2024-11-13
A study on the safety of and immune response to different doses of an mRNA vaccine against RSV in healthy adults. Ended

2024-512846-41-00 Respiratory Syncytial Virus Infections 1 2024-11-12
A Study to Learn How Safe EV25 is, the Amount of EV25 in the Body Over a Period of Time, and the Effects of EV25 on the Body in Adult Health… Ended

2024-514832-26-00 Virus Influenza 7 2024-11-12